203 related articles for article (PubMed ID: 32248621)
1. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress.
Park SY; Choi HK; Choi Y; Kwak S; Choi KC; Yoon HG
Cancer Lett; 2015 Feb; 357(1):419-427. PubMed ID: 25499082
[TBL] [Abstract][Full Text] [Related]
3. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
4. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.
Xu HY; Chen ZW; Pan YM; Fan L; Guan J; Lu YY
Dig Dis Sci; 2012 Jul; 57(7):1847-56. PubMed ID: 22359193
[TBL] [Abstract][Full Text] [Related]
5. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
[TBL] [Abstract][Full Text] [Related]
6. DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
Cui X; Choi HK; Choi YS; Park SY; Sung GJ; Lee YH; Lee J; Jun WJ; Kim K; Choi KC; Yoon HG
Cancer Lett; 2015 Feb; 357(1):307-315. PubMed ID: 25444898
[TBL] [Abstract][Full Text] [Related]
7. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
8. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.
Li F; Sun Q; Liu K; Zhang L; Lin N; You K; Liu M; Kon N; Tian F; Mao Z; Li T; Tong T; Qin J; Gu W; Li D; Zhao W
Nat Commun; 2020 Aug; 11(1):4184. PubMed ID: 32826889
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
10. OTUD5 regulates p53 stability by deubiquitinating p53.
Luo J; Lu Z; Lu X; Chen L; Cao J; Zhang S; Ling Y; Zhou X
PLoS One; 2013; 8(10):e77682. PubMed ID: 24143256
[TBL] [Abstract][Full Text] [Related]
11. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
Chen L; Han X; Hu Z; Chen L
Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
[TBL] [Abstract][Full Text] [Related]
12. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway.
Ma LY; Xie XW; Ma L; Pang JL; Xiong XM; Zheng HD; Shen XL; Wen ZG; Wang HY
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2626-2634. PubMed ID: 28678322
[TBL] [Abstract][Full Text] [Related]
13. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of OTUD5 in non-small cell lung cancer cell proliferation, invasion, and migration.
Li X; Lu B; Zhang L; Yang J; Cheng Y; Yan D
Bosn J Basic Med Sci; 2022 Oct; 22(6):901-911. PubMed ID: 35765958
[TBL] [Abstract][Full Text] [Related]
15. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Li H; Zhang X; Song X; Zhu F; Wang Q; Guo C; Liu C; Shi Y; Ma C; Wang X; Zhang L
Cancer Biol Ther; 2012 Jul; 13(9):822-30. PubMed ID: 22688731
[TBL] [Abstract][Full Text] [Related]
16. Expression of programmed cell death 5 protein inhibits progression of lung carcinoma in vitro and in vivo via the mitochondrial apoptotic pathway.
Xu S; Sui G; Yuan L; Zou Z
Mol Med Rep; 2014 Oct; 10(4):2059-64. PubMed ID: 25109624
[TBL] [Abstract][Full Text] [Related]
17. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
18. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
[TBL] [Abstract][Full Text] [Related]
19. Protein serine/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5.
Park SY; Seo J; Choi HK; Oh HJ; Guk G; Lee YH; Lee J; Jun WJ; Choi KC; Yoon HG
Sci Rep; 2017 Jan; 7():39222. PubMed ID: 28051100
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
